These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26811602)

  • 1. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.
    Akil H; Perraud A; Jauberteau MO; Mathonnet M
    World J Gastroenterol; 2016 Jan; 22(2):490-500. PubMed ID: 26811602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.
    Thomaz A; Jaeger M; Buendia M; Bambini-Junior V; Gregianin LJ; Brunetto AL; Brunetto AT; de Farias CB; Roesler R
    J Mol Neurosci; 2016 Jul; 59(3):326-33. PubMed ID: 26614346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
    Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potentials of BDNF/TrkB in Breast Cancer; Current Status and Perspectives.
    Tajbakhsh A; Mokhtari-Zaer A; Rezaee M; Afzaljavan F; Rivandi M; Hassanian SM; Ferns GA; Pasdar A; Avan A
    J Cell Biochem; 2017 Sep; 118(9):2502-2515. PubMed ID: 28230291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer.
    Mazouffre C; Geyl S; Perraud A; Blondy S; Jauberteau MO; Mathonnet M; Verdier M
    J Cell Mol Med; 2017 Oct; 21(10):2610-2622. PubMed ID: 28597984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer.
    Winder T; Lenz HJ
    Gastroenterology; 2010 Jun; 138(6):2163-76. PubMed ID: 20420953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
    Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
    Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropomyosin-related kinase B promotes distant metastasis of colorectal cancer through protein kinase B-mediated anoikis suppression and correlates with poor prognosis.
    Fan M; Sun J; Wang W; Fan J; Wang L; Zhang X; Yang A; Wang W; Zhang R; Li J
    Apoptosis; 2014 May; 19(5):860-70. PubMed ID: 24549576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
    Choy C; Ansari KI; Neman J; Hsu S; Duenas MJ; Li H; Vaidehi N; Jandial R
    Breast Cancer Res; 2017 Apr; 19(1):51. PubMed ID: 28446206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling.
    Zou W; Hu X; Jiang L
    Curr Cancer Drug Targets; 2020; 20(10):779-788. PubMed ID: 32748747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.
    Matos I; Elez E; Capdevila J; Tabernero J
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):267-82. PubMed ID: 27578253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
    Papadimitriou M; Papadimitriou CA
    Anticancer Res; 2021 Feb; 41(2):567-582. PubMed ID: 33517262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
    Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
    Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TrkB as a therapeutic target for ovarian cancer.
    Siu MK; Wong OG; Cheung AN
    Expert Opin Ther Targets; 2009 Oct; 13(10):1169-78. PubMed ID: 19694498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer.
    Grávalos C; Cassinello J; Fernández-Rañada I; Holgado E
    Clin Colorectal Cancer; 2007 Nov; 6(10):691-9. PubMed ID: 18039422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
    Pichler M; Winter E; Ress AL; Bauernhofer T; Gerger A; Kiesslich T; Lax S; Samonigg H; Hoefler G
    J Clin Pathol; 2014 Mar; 67(3):198-203. PubMed ID: 24098024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
    Zhang J; Roberts TM; Shivdasani RA
    Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.